Form 4: Intapp's Chief Product Officer, Thad Jampol, Executes Option and Sells Shares Under 10b5-1 Plan
SEC Form 4
Thad Jampol, Chief Product Officer of Intapp, Inc., exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.
Summary
- On June 10, 2024, Thad Jampol, the Chief Product Officer of Intapp, Inc., exercised options to purchase 15,000 shares of common stock at a price of $3.99 per share.
- Simultaneously, Jampol sold 8,690 shares at a weighted average price of $34.357 and 6,310 shares at a weighted average price of $35.1004.
- These transactions were executed under a 10b5-1 trading plan established on December 13, 2023.
- Following these transactions, Jampol directly owns 749,652 shares of Intapp common stock.
- Jampol also has indirect ownership through his spouse (34,972 shares) and two trusts (15,028 shares each).
- He also holds options for 404,198 shares.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
This Form 4 filing is a routine disclosure related to insider trading activity. It indicates that a company executive is exercising stock options and selling shares, which is a common practice, especially under pre-arranged trading plans like 10b5-1 plans. These plans allow insiders to sell shares at predetermined times and prices, avoiding concerns about trading on non-public information.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their insiders.
- The use of 10b5-1 plans is a common method for executives to manage their stock holdings while complying with insider trading regulations.
- Comparable companies would have similar filings when their executives exercise options or sell shares.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increase in the number of shares available in the market.
- The impact is likely to be minimal as the transactions were executed under a pre-arranged 10b5-1 trading plan.
Key Dates
| Date | Description |
|---|---|
| 12/13/2023 | Date the 10b5-1 plan was put in place by the Reporting Person |
| 06/10/2024 | Date of the transaction (option exercise and stock sale) |
| 06/12/2024 | Date of signature on the Form 4 filing |
| 08/27/2025 | Expiration date of the Employee Stock Option |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.